Acyl sulfamides for treatment of obesity, diabetes and lipid disorders
US6852738B2 · kind B2 · utility
12Cited by
2References
26Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 25, 2002 |
| Grant date | Feb 8, 2005 |
| Priority date | — |
| Expiry date | Jan 31, 2022 |
Classification
- Technology area (CPC F)Mechanical Engineering; Lighting; Heating
- CPC primaryF16M2200/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A class of acyl sulfamides comprises compounds that are potent ligands for PPAR gamma and generally have antagonist or partial agonist activity. The compounds may be useful in the treatment, control or prevention of obesity, non-insulin dependent diabetes mellitus (NIDDM), hyperglycemia, dyslipidemia, hyperlipidemia, hypercholesterolemia, hypertriglyceridemia, atherosclerosis, vascular restenosis, inflammation, and other PPAR gamma mediated diseases, disorders and conditions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.